CA pressures drug maker on AIDS drug costs
SACRAMENTO, Calif. -- California is pressuring Bristol-Myers Squibb to reduce the cost of a key AIDS medication.
The drug giant's Reyataz is one of the most common drugs to treat AIDS patients, and it's the most costly with an average wholesale price of $13,046 a year.
State Controller John Chiang wrote Bristol-Myers Squibb this month to urge the company to join other pharmaceutical companies that have found ways to reduce the cost of drugs to California.
The giant California retirement funds CalPERS and CalSTRS, which have investments in Bristol-Myers Squibb, also sent letters urging a cut in the cost of the anti-retroviral drug.
Bristol-Myers Squibb accounts for about 30 percent of all drugs purchased in California to treat AIDS patients.
aids, california news
- CO school shooting suspect dead, says sheriff 22 min ago
- Car bomb plot thwarted at Kansas airport 27 min ago
- Body found near East Los Angeles College
- Help Garth stuff buses full of toys in Canoga Park
- SoCal boy's cancer fight inspires
- OC homicide: Roommate sought for questioning 39 min ago
- Man burned in fire at Long Beach VA Hospital
- 24 students arrested in school drug ring case
- 2nd woman in purported mercy killings ID'd
- Mega Millions jackpot rockets to $425 million 52 min ago
- Mom with cancer inspires daughter's friend
- Bruno Mars named Billboard's 2013 top artist
- Beyonce releases surprise album on iTunes
- OTRC: Bradley Cooper talks 'American Hustle'